Cited by 45Immunotherapy and Immune ResponsesT-cell and B-cell Immunologyvaccines and immunoinformatics approaches

Expression and trafficking of MR1

Open access
Lamichhane, Rajesh, Ussher, James E.·2017·Immunology

Abstract

Summary: MHC class I‐related gene protein (MR1) is a non‐polymorphic MHC class IB antigen‐presenting molecule that is the restricting molecule for mucosal‐associated invariant T (MAIT) cells, a prominent population of innate‐like antibacterial T cells. The MAIT cell–MR1 axis represents a new paradigm in antigen presentation, with the MR1 ligand derived from vitamin B compounds or their metabolic precursors. Many bacteria and some fungi produce the activating ligand for MR1. In evolution, MR1 is highly conserved in most, but not all, mammals. In humans and rodents it is expressed in a broad range of cell types, both haematopoietic and non‐haematopoietic, although cell surface expression has been difficult to detect. Although MR1 trafficking shares features with both the MHC class I and MHC class II pathways, it is distinct. Several strands of evidence suggest that the intracellular location where MR1 is loaded differs for soluble ligand and for ligand derived from intact bacteria. The regulation of MR1 surface expression may also vary between different cell types. This paper will review what is currently known about the expression and trafficking of MR1 and propose a model for the loading and trafficking of MR1.

Integrity signals

Registry

Crossref · 10.1111/imm.12744

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Lamichhane, R., & Ussher, J. E.
Affiliations
University of Otago (NZ)
Corresponding author
Ussher, James E.
Venue
Immunology
Publisher
Wiley
Published
2017-05-18
Volume
151
Issue
3
Pages
270-279
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W2606512914
Cited by
45
References
0
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 1 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 7 · 2018: 3 · 2017: 4
FWCI
0.51
Type
journal article
Language
en
Open access
Locations
  • Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
MR1, mucosal-associated invariant T cells, antigen presentation, antigen loading, MHC class Ib, innate-like T cells, bacterial ligands
MeSH terms
Amino Acid Sequence, Animals, Gene Expression Regulation, Humans, Ligands, RNA, Messenger, T-Lymphocytes, Histocompatibility Antigens Class I, Signal Transduction, Minor Histocompatibility Antigens, Conserved Sequence, Evolution, Molecular, Protein Transport

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review